PTGS2 and breast carcinoma: For example, breast cancer patients with elevated levels of COX2 and PGE2 within the tumor and the circulation presented T cells with decreased proliferation in response to CD3 antibody stimulation, reduced levels of TNF-α, interleukin (IL)-12, IL-2, and increased levels of IL-10 and IL-4.